Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study

Simple item page
dc.contributor.authorAndia Biraro, Irene
dc.contributor.authorEgesa, Moses
dc.contributor.authorKimuda, Simon
dc.contributor.authorSmith, Steven G.
dc.contributor.authorToulza, Frederic
dc.contributor.authorLevin, Jonathan
dc.contributor.authorJoloba, Moses
dc.contributor.authorKatamba, Achilles
dc.contributor.authorCose, Stephen
dc.contributor.authorHazel M., Dockrell
dc.contributor.authorElliott, Alison M.
dc.date.accessioned2023-01-18T15:35:05Z
dc.date.available2023-01-18T15:35:05Z
dc.date.issued2015
dc.description.abstractWith the renewed emphasis to implement isoniazid preventive therapy (IPT) in Sub-Saharan Africa, we investigated the effect of IPT on immunological profiles among household contacts with latent tuberculosis. Methods: Household contacts of confirmed tuberculosis patients were tested for latent tuberculosis using the QuantiFERON®-TB Gold In-Tube (QFN) assay and tuberculin skin test (TST). HIV negative contacts aged above 5 years, positive to both QFN and TST, were randomly assigned to IPT and monthly visits or monthly visits only. QFN culture supernatants from enrolment and six months’ follow-up were analysed for M.tb-specific Th1, Th2, Th17, and regulatory cytokines by Luminex assay, and for M.tb-specific IgG antibody concentrations by ELISA. Effects of IPT were assessed as the net cytokine and antibody production at the end of six months. Results: Sixteen percent of contacts investigated (47/291) were randomised to IPT (n = 24) or no IPT (n = 23). After adjusting for baseline cytokine or antibody responses, and for presence of a BCG scar, IPT (compared to no IPT) resulted in a relative decline in M.tb-specific production of IFN gamma (adjusted mean difference at the end of six months (bootstrap 95 % confidence interval (CI), p-value) -1488.6 pg/ml ((−2682.5, −294.8), p = 0.01), and IL- 2 (−213.1 pg/ml (−419.2, −7.0), p = 0.04). A similar decline was found in anti-CFP-10 antibody levels (adjusted geometric mean ratio (bootstrap 95 % CI), p-value) 0.58 ((0.35, 0.98), p = 0.04). We found no effect on M.tb-specific Th2 or regulatory or Th17 cytokine responses, or on antibody concentrations to PPD and ESAT-6. Conclusions: IPT led to a decrease in Th1 cytokine production, and also in the anti CFP-10 antibody concentration. This could be secondary to a reduction in mycobacterial burden or as a possible direct effect of isoniazid induced T cell apoptosis, and may have implications for protective immunity following IPT in tuberculosis-endemic countries.en_US
dc.identifier.citationBiraro, I. A., Egesa, M., Kimuda, S., Smith, S. G., Toulza, F., Levin, J., ... & Elliott, A. M. (2015). Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study. BMC infectious diseases, 15(1), 1-12. DOI 10.1186/s12879-015-1201-8en_US
dc.identifier.other10.1186/s12879-015-1201-8
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7024
dc.language.isoenen_US
dc.publisherBMC infectious diseasesen_US
dc.subjectLatent tuberculosis infectionen_US
dc.subjectHousehold contactsen_US
dc.subjectRandomised designen_US
dc.subjectCytokinesen_US
dc.subjectAntibodiesen_US
dc.subjectIsoniazid preventive therapyen_US
dc.titleEffect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Effect of isoniazid preventive therapy on.pdf
Size:
940.5 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences